To utilize our resources and resource allocation capabilities as a non-profit company to further developments in Alzheimer's research and treatment by leveraging Artificial Intelligence, Machine Learning, Intelligent Automation and Blockchain/Hyperledger technologies to identify, collect, prioritize, and support relevant global research in order to more effectively support the most promising treatments.
By leveraging our combined technical expertise (UX, SaaS, PaaS, Cloud, BTF, Machine Learning/Artificial Intelligence, Cybersecurity, Blockchain and Information Governance), and accessing our industry colleagues, and networks, we work to create an ecosystem for a solution.
The past year has brought some disappointing results from clinical trials testing new Alzheimer’s drugs and processes.
On top of that, a handful of pharmaceutical companies have bowed out of Alzheimer’s drug development altogether.
We want to further developments in the future of Alzheimer's research to connect the one trillion dollar global spend and harness a connection.
Members Leveraging Spend for Artificial Intelligence, Intelligent Automation Leading Pharmas and Universities to Channel the 1 Trillion Dollar Global Investment to maximize results.
When our relatives and their decedents, us, are unlikely to repeat the conditions in their full amplitude - then we have made a difference.
PlateRate - Eat Good. Feel Good. Do Good.
Cyber Defense Magazine is by ethical, honest, passionate information security professionals for IT Security professionals. Our mission is to share cutting edge knowledge, real-world stories and awards on the best ideas, products and services in the information technology industry.